Penton Pharmaceuticals Galveston, TX - 77554

Penton Pharmaceuticals is categorized under Toxins, Viruses, and Similar Substances, Including Venom in Galveston, TX and active since 2003.

Penton Pharmaceuticals was established in 2003, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Toxins, Viruses, and Similar Substances, Including Venom business, which does work in the B2B market, and is classified as a Toxins, Viruses, and Similar Substances, Including Venom, under code number 325414 by the NAICS.

If you are seeking more information, feel free to contact Robert Fox at the company’s single location by writing to 8 Quintana Drive, Galveston, Texas TX 77554 or by phoning (409) 771-2152. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Penton Pharmaceuticals
Contact Person: Robert Fox
Address: 8 Quintana Drive, Galveston, Texas 77554
Phone Number: (409) 771-2152
Annual Revenue (USD): $50.000 to $99.999
Founded: 2003
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Toxins, Viruses, and Similar Substances, Including Venom
SIC Code: 2836
NAICS Code: 325414
Share This Business:

Penton Pharmaceuticals was started in 2003 to provide professional Toxins, Viruses, and Similar Substances, Including Venom under the SIC code 2836 and NAICS code 325414. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.

Feel free to contact Robert Fox for inquiries that concern Penton Pharmaceuticals by calling the company number (409) 771-2152, as your correspondence is most welcome. Additionally, the physical location of the single location of Penton Pharmaceuticals can be found at the coordinates 29.253104,-94.870412 as well as the street address 8 Quintana Drive in Galveston, Texas 77554.

For its online presence, you may visit Penton Pharmaceuticals’s website at and engage with its social media outlets through on Twitter and on Facebook.